Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Thorax 2006;61:551; doi:10.1136/thx.2006.awjul06
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedzicha, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wedzicha, W.
Topic Collections
Right arrowRelevant Articles

Airwaves

Wisia Wedzicha, Editor in Chief

The first 150 words of the full text of this article appear below.


COMBINATION THERAPIES FOR COPD
As Casaburi points out in his accompanying editorial to the paper by Peters and colleagues, COPD is now recognised as distinctly not a disease of irreversible airflow obstruction. A number of pharmacological and non-pharmacological interventions have shown reduction of dyspnoea and improvement of exercise capacity, but we have little information on the additive effects of these therapies and, indeed, this is how they will be used in practice. In this issue of Thorax Peters and colleagues show, for the first time, additive effects on dyspnoea and exercise capacity of bronchodilator therapy and supplemental oxygen in normoxic COPD patients. Endurance time increased by 16% with bronchodilators compared with placebo, by 28% with oxygen alone, and by 40% with the combination of bronchodilator and oxygen compared with the endurance time achieved on room air and placebo. The paper also describes some interesting insights into the mechanisms of these improvements and sets the . . . [Full text of this article]


Relevant Articles

Combination therapy for exercise intolerance in COPD
R Casaburi
Thorax 2006 61: 551-552. [Extract] [Full Text] [PDF]

High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis
K Thorburn, S Harigopal, V Reddy, N Taylor, and H K F van Saene
Thorax 2006 61: 611-615. [Abstract] [Full Text] [PDF]

Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD
M M Peters, K A Webb, and D E O’Donnell
Thorax 2006 61: 559-567. [Abstract] [Full Text] [PDF]

Smoking related COPD and facial wrinkling: is there a common susceptibility?
B D Patel, W J Loo, A D Tasker, N J Screaton, N P Burrows, E K Silverman, and D A Lomas
Thorax 2006 61: 568-671. [Abstract] [Full Text] [PDF]

Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma
T H Harju, M Leinonen, J Nokso-Koivisto, T Korhonen, R Räty, Q He, T Hovi, J Mertsola, A Bloigu, P Rytilä, and P Saikku
Thorax 2006 61: 579-584. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society